183 related articles for article (PubMed ID: 24490140)
1. A novel cell-penetrating peptide derived from WT1 enhances p53 activity, induces cell senescence and displays antimelanoma activity in xeno- and syngeneic systems.
Massaoka MH; Matsuo AL; Figueiredo CR; Girola N; Faria CF; Azevedo RA; Travassos LR
FEBS Open Bio; 2014; 4():153-61. PubMed ID: 24490140
[TBL] [Abstract][Full Text] [Related]
2. A subtraction tolerization method of immunization allowed for Wilms' tumor protein-1 (WT1) identification in melanoma and discovery of an antitumor peptide sequence.
Massaoka MH; Matsuo AL; Figueiredo CR; Girola N; Farias CF; Pasqualoto K; Travassos LR
J Immunol Methods; 2014 Dec; 414():11-9. PubMed ID: 25205401
[TBL] [Abstract][Full Text] [Related]
3. RNAi silencing of the WT1 gene inhibits cell proliferation and induces apoptosis in the B16F10 murine melanoma cell line.
Zamora-Avila DE; Franco-Molina MA; Trejo-Avila LM; Rodríguez-Padilla C; Reséndez-Pérez D; Zapata-Benavides P
Melanoma Res; 2007 Dec; 17(6):341-8. PubMed ID: 17992115
[TBL] [Abstract][Full Text] [Related]
4. Peptide R18H from BRN2 Transcription Factor POU Domain Displays Antitumor Activity In Vitro and In Vivo and Induces Apoptosis in B16F10-Nex2 Cells.
da Cunha FFM; Mugnol KCU; de Melo FM; Nascimento MVSQ; de Azevedo RA; Santos RTS; Magalhães JA; Miguel DC; Tada DB; Mortara RA; Travassos LR; Arruda DC
Anticancer Agents Med Chem; 2019; 19(3):389-401. PubMed ID: 30417795
[TBL] [Abstract][Full Text] [Related]
5. The zinc finger domain of Wilms' tumor 1 suppressor gene (WT1) behaves as a dominant negative, leading to abrogation of WT1 oncogenic potential in breast cancer cells.
Han Y; San-Marina S; Yang L; Khoury H; Minden MD
Breast Cancer Res; 2007; 9(4):R43. PubMed ID: 17634147
[TBL] [Abstract][Full Text] [Related]
6. Expression of the wt1 Wilms' tumor gene by normal and malignant human melanocytes.
Rodeck U; Bossler A; Kari C; Humphreys CW; Györfi T; Maurer J; Thiel E; Menssen HD
Int J Cancer; 1994 Oct; 59(1):78-82. PubMed ID: 7927908
[TBL] [Abstract][Full Text] [Related]
7. A novel microtubule de-stabilizing complementarity-determining region C36L1 peptide displays antitumor activity against melanoma in vitro and in vivo.
Figueiredo CR; Matsuo AL; Azevedo RA; Massaoka MH; Girola N; Polonelli L; Travassos LR
Sci Rep; 2015 Sep; 5():14310. PubMed ID: 26391685
[TBL] [Abstract][Full Text] [Related]
8. Classification of a frameshift/extended and a stop mutation in WT1 as gain-of-function mutations that activate cell cycle genes and promote Wilms tumour cell proliferation.
Busch M; Schwindt H; Brandt A; Beier M; Görldt N; Romaniuk P; Toska E; Roberts S; Royer HD; Royer-Pokora B
Hum Mol Genet; 2014 Aug; 23(15):3958-74. PubMed ID: 24619359
[TBL] [Abstract][Full Text] [Related]
9. Wilms' tumour-suppressor protein isoforms have opposite effects on Igf2 expression in primary embryonic cells, independently of p53 genotype.
Duarte A; Caricasole A; Graham CF; Ward A
Br J Cancer; 1998; 77(2):253-9. PubMed ID: 9460996
[TBL] [Abstract][Full Text] [Related]
10. The WT1 gene product stabilizes p53 and inhibits p53-mediated apoptosis.
Maheswaran S; Englert C; Bennett P; Heinrich G; Haber DA
Genes Dev; 1995 Sep; 9(17):2143-56. PubMed ID: 7657166
[TBL] [Abstract][Full Text] [Related]
11. E47 Governs the MYC-CDKN1B/p27
Scully KM; Lahmy R; Signaevskaia L; Sasik R; Medal R; Kim H; French R; James B; Wu Y; Lowy AM; Itkin-Ansari P
Cell Mol Gastroenterol Hepatol; 2018; 6(2):181-198. PubMed ID: 30003124
[TBL] [Abstract][Full Text] [Related]
12. Andrographolide, a diterpene lactone from the Traditional Chinese Medicine Andrographis paniculate, induces senescence in human lung adenocarcinoma via p53/p21 and Skp2/p27.
Zhang J; Li C; Zhang L; Heng Y; Wang S; Pan Y; Cai L; Zhang Y; Xu T; Chen X; Hoffman RM; Jia L
Phytomedicine; 2022 Apr; 98():153933. PubMed ID: 35121394
[TBL] [Abstract][Full Text] [Related]
13. Functional properties of WT1.
Haber DA; Englert C; Maheswaran S
Med Pediatr Oncol; 1996 Nov; 27(5):453-5. PubMed ID: 8827073
[TBL] [Abstract][Full Text] [Related]
14. Induction of p21 by the Wilms' tumor suppressor gene WT1.
Englert C; Maheswaran S; Garvin AJ; Kreidberg J; Haber DA
Cancer Res; 1997 Apr; 57(8):1429-34. PubMed ID: 9108440
[TBL] [Abstract][Full Text] [Related]
15. The oncogenic properties of EWS/WT1 of desmoplastic small round cell tumors are unmasked by loss of p53 in murine embryonic fibroblasts.
Bandopadhayay P; Jabbour AM; Riffkin C; Salmanidis M; Gordon L; Popovski D; Rigby L; Ashley DM; Watkins DN; Thomas DM; Algar E; Ekert PG
BMC Cancer; 2013 Dec; 13():585. PubMed ID: 24321497
[TBL] [Abstract][Full Text] [Related]
16. Induction of Wilms' tumor protein (WT1)-specific antitumor immunity using a truncated WT1-expressing adenovirus vaccine.
Osada T; Woo CY; McKinney M; Yang XY; Lei G; Labreche HG; Hartman ZC; Niedzwiecki D; Chao N; Amalfitano A; Morse MA; Lyerly HK; Clay TM
Clin Cancer Res; 2009 Apr; 15(8):2789-96. PubMed ID: 19351755
[TBL] [Abstract][Full Text] [Related]
17. Dimethylfumarate inhibits melanoma cell proliferation via p21 and p53 induction and bcl-2 and cyclin B1 downregulation.
Kaluzki I; Hrgovic I; Hailemariam-Jahn T; Doll M; Kleemann J; Valesky EM; Kippenberger S; Kaufmann R; Zoeller N; Meissner M
Tumour Biol; 2016 Oct; 37(10):13627-13635. PubMed ID: 27468725
[TBL] [Abstract][Full Text] [Related]
18. PPARbeta activation inhibits melanoma cell proliferation involving repression of the Wilms' tumour suppressor WT1.
Michiels JF; Perrin C; Leccia N; Massi D; Grimaldi P; Wagner N
Pflugers Arch; 2010 Apr; 459(5):689-703. PubMed ID: 20066433
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic Effects of WT1 Silencing via Respiratory Administration of Neutral DOPC Liposomal-siRNA in a Lung Metastasis Melanoma Murine Model.
Ramos-Gonzalez MR; Vazquez-Garza E; Garcia-Rivas G; Rodriguez-Aguayo C; Chavez-Reyes A
Noncoding RNA; 2023 Mar; 9(2):. PubMed ID: 36960966
[TBL] [Abstract][Full Text] [Related]
20. Wilms tumor 1 (WT1) regulates KRAS-driven oncogenesis and senescence in mouse and human models.
Vicent S; Chen R; Sayles LC; Lin C; Walker RG; Gillespie AK; Subramanian A; Hinkle G; Yang X; Saif S; Root DE; Huff V; Hahn WC; Sweet-Cordero EA
J Clin Invest; 2010 Nov; 120(11):3940-52. PubMed ID: 20972333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
